Fortis Healthcare Limited (FORTIS) Q2 FY27 Financial Results: PAT ₹263 Cr & Revenue ₹2,545 Cr

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
MetricValue
Revenue₹2,545 Cr
Net Profit (PAT)₹263 Cr
📢 Key Event
Fortis Healthcare reported Q1 FY27 revenue of ₹2,545 crores and net profit of ₹263 crores.
🔄 What Changed
Net profit growth of 4% and diagnostics EBITDA margin improvement to 23.9%
🔮 What's Next
Target 25% EBITDA margin by FY28 post-ESOP, with ESOP charges declining to ₹25 crore in year three
💡 Investor Takeaway
The company is prioritizing margin expansion through strategic expansions and operational improvements while managing ESOP-related costs.

Fortis Healthcare reported consolidated revenue of ₹2,545 crores in Q1 FY27, up 17.5% YoY, with net profit after tax at ₹263 crores, up ~4%. Operating EBITDA stood at ₹568 crores (22.3% margin), and diagnostics revenue grew 10.2% to [amount context mismatch] crores with a 23.9% EBITDA margin. The company highlighted hospital occupancy improvements, bed expansions in Manesar and Noida, and oncology equipment rollout by November. Strategic focus includes calibrated ESOP rollout, margin improvement to 25% by FY28, and expansion into Odisha and new diagnostic centers.

📄 View Original Announcement (PDF)

About Fortis Healthcare Limited (FORTIS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹68,769.14 Cr P/E: 65.6 ROE: 10.8% ROCE: 13.3% Div Yield: 0.11%

View full FORTIS stock details →

📡 Get AI alerts when FORTIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FORTIS — Free

📊 More FORTIS filings

See all FORTIS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FORTIS files new disclosures

Track FORTIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FORTIS — Free

Free account · 2 AI queries/day